Stay updated on Oral Ixazomib Maintenance in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Oral Ixazomib Maintenance in Myeloma Clinical Trial page.

Latest updates to the Oral Ixazomib Maintenance in Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision label v3.4.2 appears, replacing the previous v3.4.1 in the history list, reflecting a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded Revision: v3.4.1 to the history and removed Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0 from the history.SummaryDifference0.1%

- Check27 days agoChange DetectedUI/metadata updates only: a glossary toggle and color-coded change highlights were added, and the revision label was updated from v3.3.4 to v3.4.0. The No FEAR Act data note was adjusted.SummaryDifference0.7%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the Study Record Versions history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.3.3 was added to the page history. The HHS Vulnerability Disclosure entry and the Revision: v3.3.2 entry were removed.SummaryDifference0.1%

Stay in the know with updates to Oral Ixazomib Maintenance in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Ixazomib Maintenance in Myeloma Clinical Trial page.